Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749059 · ClinicalTrials.gov registry record
The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease
A clinical trial of Congenital Heart Disease, sponsored by Pediatrix.
- Completed
- Registry status
- 6,147
- Enrollment target
- 1
- Study location
NCT01749059 is a study of Congenital Heart Disease that has completed, run by Pediatrix. The registered enrollment target is 6,147 participants, above the 376-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (1535% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01749059, a study of Congenital Heart Disease, has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 6,147 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the impact of implementing a universal pulse oximeter screening as a way to detect critical congenital heart disease in otherwise well-appearing newborns.
Conditions Studied
Study Locations (1)
New Jersey
- Capital Health Regional Medical Center - Pediatrix Medical Group - Trenton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,147 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01749059
The ClinicalTrials.gov registry entry for NCT01749059 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,147 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 376-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (1535% higher). The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01749059 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT01749059 about?
NCT01749059 is a clinical study titled "The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease". The purpose of this study is to evaluate the impact of implementing a universal pulse oximeter screening as a way to detect critical congenital heart disease in otherwise well-appearing newborns.
What is the current status of trial NCT01749059?
This trial is currently completed. The enrollment target is 6,147 participants. The study started on 2012-06. Estimated completion is 2016-10.
What conditions does trial NCT01749059 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
Who is sponsoring clinical trial NCT01749059?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01749059 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.